JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Busch, H.
Right arrow Articles by Nyhan, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Busch, H.
Right arrow Articles by Nyhan, W. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 127, Issue 3, 195-199, 1959
Copyright © 1959 by American Society for Pharmacology and Experimental Therapeutics


INHIBITION OF UPTAKE OF L-ARGININE-U-C14 INTO NUCLEAR PROTEINS BY 5-BIS (2-CHLOROETHYL) AMINOURACIL

Harris Busch 1, Samir M. Amer 1, and William L. Nyhan 1

1 Department of Pharmacology, University of Illinois, College of Medicine, Chicago, Illinois

At various time intervals following the administration of 1 to 4 mg/kg of 5-bis (2-chloroethyl) aminouracil to rats bearing the Walker 256 carcinosarcoma, 7.5 µc of L-arginine-U-C14 was injected. An hour later, the tissues were excised and the specific activities of the proteins of the intracellular fractions were determined.

The data obtained provide in vivo evidence that the primary site of action of the aminouracil mustard is in the nucleus. The drug particularly affects the systems which are involved in the biosynthesis of the acid insoluble nuclear proteins. This intracellular selectivity of action was demonstrated for the Walker tumor and the spleen which are the biological sites of inhibitory action of this compound. The effect on the spleen was more marked than the effect on the tumor. The drug had virtually no effect on the incorporation of the labeled isotope into the cytoplasmic proteins of the tissues studied.

Submitted on May 7, 1959







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1959 by the American Society for Pharmacology and Experimental Therapeutics.